Longer term patient management following stroke: A systematic review.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 6 5 2021
medline: 12 11 2021
entrez: 5 5 2021
Statut: ppublish

Résumé

Tremendous progress in acute stroke therapy has improved short-term outcome but part of this achievement may be lost in the long run. Concepts for a better long-term management of stroke survivors are needed to address their unmet needs and to reduce the burden of post-stroke complications, residual deficits, and recurrent vascular events. This review summarizes current knowledge on post-hospital care and the scientific evidence supporting individual programs. A systematic search of electronic databases according to PRISMA guidelines identified 10,374 articles, 77 of which met the inclusion criteria. One large randomised controlled trial on a multifaceted care program delivered by the multidisciplinary stroke team reduced recurrent vascular events and improved quality of life and functional outcome one year after the event, while a number of studies offer solutions for individual components of post-hospital disease management like patient education, counselling, and self-management or the management of post-stroke complications and residual deficits. A majority of studies, however, was small in size and limited by a short follow-up. Most initiatives with a narrow focus on risk factor control failed to lower the risk of recurrent events. The caregivers' central role in post-stroke patient management is broadly neglected in research. Over the past years, first knowledge on how to best organize post-hospital care of stroke patients has emerged. Comprehensive and pragmatic programs operated by the multidisciplinary stroke team hold promise to reduce the long-term health burden of stroke. There is a clear need for further high-quality studies with both clinical endpoints and patient-reported outcomes to establish sustainable solutions in different settings and regions to improve life after stroke, a key priority of the Stroke Action Plan for Europe 2018-2030.

Sections du résumé

BACKGROUND
Tremendous progress in acute stroke therapy has improved short-term outcome but part of this achievement may be lost in the long run. Concepts for a better long-term management of stroke survivors are needed to address their unmet needs and to reduce the burden of post-stroke complications, residual deficits, and recurrent vascular events.
AIMS
This review summarizes current knowledge on post-hospital care and the scientific evidence supporting individual programs.
SUMMARY OF REVIEW
A systematic search of electronic databases according to PRISMA guidelines identified 10,374 articles, 77 of which met the inclusion criteria. One large randomised controlled trial on a multifaceted care program delivered by the multidisciplinary stroke team reduced recurrent vascular events and improved quality of life and functional outcome one year after the event, while a number of studies offer solutions for individual components of post-hospital disease management like patient education, counselling, and self-management or the management of post-stroke complications and residual deficits. A majority of studies, however, was small in size and limited by a short follow-up. Most initiatives with a narrow focus on risk factor control failed to lower the risk of recurrent events. The caregivers' central role in post-stroke patient management is broadly neglected in research.
CONCLUSIONS
Over the past years, first knowledge on how to best organize post-hospital care of stroke patients has emerged. Comprehensive and pragmatic programs operated by the multidisciplinary stroke team hold promise to reduce the long-term health burden of stroke. There is a clear need for further high-quality studies with both clinical endpoints and patient-reported outcomes to establish sustainable solutions in different settings and regions to improve life after stroke, a key priority of the Stroke Action Plan for Europe 2018-2030.

Identifiants

pubmed: 33949269
doi: 10.1177/17474930211016963
pmc: PMC8554494
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

917-926

Références

Cerebrovasc Dis. 2008;25(5):423-9
pubmed: 18349536
Stroke. 2017 Sep;48(9):2504-2510
pubmed: 28754834
N Engl J Med. 2018 Dec 20;379(25):2429-2437
pubmed: 30575491
Stroke. 2019 Mar;50(3):705-712
pubmed: 30802185
J Clin Nurs. 2007 Feb;16(2):272-81
pubmed: 17239062
Lancet Neurol. 2020 Jan;19(1):49-60
pubmed: 31708447
Health Educ Res. 2013 Jun;28(3):488-501
pubmed: 23515115
Lancet Neurol. 2019 May;18(5):459-480
pubmed: 30879893
CMAJ. 2014 May 13;186(8):577-84
pubmed: 24733770
Stroke. 2015 Dec;46(12):3451-8
pubmed: 26508749
JAMA. 2015 Apr 14;313(14):1451-62
pubmed: 25871671
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Int J Stroke. 2020 Dec;15(9):954-964
pubmed: 32293236
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105482
pubmed: 33253985
Stroke. 2016 Jul;47(7):1885-92
pubmed: 27301941
Cerebrovasc Dis. 2013;36(2):88-97
pubmed: 24029303
Eur J Prev Cardiol. 2015 Oct;22(10):1354-62
pubmed: 25139770
J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):279-84
pubmed: 19010943
Eur J Neurol. 2017 Jul;24(7):920-928
pubmed: 28488353
BMJ Open. 2020 Jun 11;10(6):e035850
pubmed: 32532772
BMJ. 2008 Feb 16;336(7640):376-9
pubmed: 18230644
Stroke. 2007 Jun;38(6):1899-904
pubmed: 17510453
BMC Neurol. 2018 Sep 21;18(1):153
pubmed: 30241499
Neurology. 2019 Dec 3;93(23):e2121-e2132
pubmed: 31672716
Stroke. 2020 Nov;51(11):3452-3460
pubmed: 33070713
EClinicalMedicine. 2020 Jul 28;25:100476
pubmed: 32954239
Stroke. 2014 Nov;45(11):3330-6
pubmed: 25248910
Cochrane Database Syst Rev. 2018 May 07;5:CD009103
pubmed: 29734470
Ann Intern Med. 2005 Nov 1;143(9):659-72
pubmed: 16263889
Stroke. 2018 Feb;49(2):426-432
pubmed: 29284737
PLoS One. 2015 Oct 16;10(10):e0139997
pubmed: 26474055
Lancet Oncol. 2017 Jan;18(1):e19-e29
pubmed: 28049574
Stroke. 2014 Feb;45(2):515-9
pubmed: 24385269
Stroke. 2017 Jan;48(1):174-179
pubmed: 27924055
J Stroke Cerebrovasc Dis. 2011 Jan-Feb;20(1):16-23
pubmed: 21187254
Stroke. 2015 Oct;46(10):2874-80
pubmed: 26374482
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e173-80
pubmed: 23265778
Eur Stroke J. 2018 Dec;3(4):309-336
pubmed: 31236480
Stroke. 2010 Nov;41(11):2470-6
pubmed: 20864664
Clin Rehabil. 2019 Feb;33(2):262-276
pubmed: 30409049
BMC Neurol. 2017 Jul 17;17(1):133
pubmed: 28716014
Lancet Neurol. 2015 Jan;14(1):48-56
pubmed: 25435129
Lancet. 2013 Dec 21;382(9910):2069-76
pubmed: 24054816
Int J Stroke. 2020 Jun;15(4):438-453
pubmed: 30785379
Brain Behav. 2016 Apr 28;6(5):e00455
pubmed: 27257517
Int J Stroke. 2014 Oct;9(7):932-8
pubmed: 23205666

Auteurs

Christian Boehme (C)

Department of Neurology, 27280Medical University of Innsbruck, Innsbruck, Austria.

Thomas Toell (T)

Department of Neurology, 27280Medical University of Innsbruck, Innsbruck, Austria.

Wilfried Lang (W)

Department of Neurology, Hospital St. John's of God, Vienna, Austria.

Michael Knoflach (M)

Department of Neurology, 27280Medical University of Innsbruck, Innsbruck, Austria.
VASCage, Research Centre on Vascular Ageing and Stroke, Innsbruck, Austria.

Stefan Kiechl (S)

Department of Neurology, 27280Medical University of Innsbruck, Innsbruck, Austria.
VASCage, Research Centre on Vascular Ageing and Stroke, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH